purpose make world smarter happier richer founded motley fool financial service company dedicated making world smarter happier richer motley fool reach million people every month premium investing solution free guidance market analysis foolcom toprated podcasts nonprofit motley fool foundation purpose make world smarter happier richer founded motley fool financial service company dedicated making world smarter happier richer motley fool reach million people every month premium investing solution free guidance market analysis foolcom toprated podcasts nonprofit motley fool foundation amrn earnings call period ending december image source motley fool amarin plc amrn q earnings callfeb etcontents prepared remark question answer call participant prepared remark operatorwelcome amarin corporation conference call discus fourth quarter full year financial result business update would like turn conference call mark marmur vice president corporate communication amarinmark marmur vice president corporate communication good morning everyone thank joining u turning forwardlooking statement please aware conference call contain forwardlooking statement intended covered safe harbor provided federal security law may achieve goal carry plan intention meet expectation disclosed forwardlooking statement actual result event could differ materially place undue reliance statement assume obligation update statement circumstance change forwardlooking statement reflect potential impact significant transaction may enter merger acquisition disposition joint venture material agreement may enter amend terminate additional information concerning risk factor could cause actual result differ materially please see risk factor section annual report form k year ended december filed sec available investor relation section website wwwamarincorpcomwe encourage everyone read document archive call posted amarins website investor relation section turning today agenda patrick holt amarins president chief executive officer provide brief overview highlight priority tom reilly amarins chief financial officer provide review fourth quarter full year financial result following prepared remark open call question turn call patrick holt president chief executive officer amarin pat patrick holt president chief executive officer thank mark good morning everyone thank joining u today review highlight priority want take moment reflect strategy amarin every day team focused driving operational momentum maximize patient uptake vascepavazkepa enhance value amarin deliver shareholder value must drive operational momentum across three key region europe potential ip runway focusing effort investment accelerate prescription growth revenue well secure pricing reimbursement key market yous maintaining extending ipe market leadership rest world enabling partner get product hand many patient possible firmly believe focus operational momentum best path forward amarin strongly position u potential future option turning slide believe strategy best way deliver shareholder value today way gain shareholder confidence deliver made meaningful progress clear priority place europe new leadership focused strategy place team made launch progress advanced pricing reimbursement goal spain team focusing healthcare practitioner early adopter cardiovascular product continuing deliver strong launch progress approximately patient therapy united kingdom focused strategy place including driving uptake key account currently least patient therapy turning pricing reimbursement secured pricing reimbursement across nine country europe shared previously strengthened focus advance opportunity key eu five market pleased share italy resubmitted dossier advance process authority potentially achieve market access vazkepa end france germany sharpening scientific argument strategy plan place advance submission vazkepa market expect process conclude continue communicate progress france germany additional step achieved importantly also aiming successfully conclude pricing reimbursement decision least five additional market remain confident path forward europe patent application potential extend ip testament progress successfully defended patent opposition expect share topic coming month turning united state continue extend ipe market leadership closing year market share achieved focused investment managed care trade medical capability extend vascepas life cycle despite elimination sale force reduced marketing spend july turn begun year slightly improved position compared last year based currently know exclusive account represent least total ipe market volume encouraged start year solid managed care position market remains highly dynamic continue monitor closely expect q result impacted typical first quarter payer dynamic continue stand ready execute aggressive approach including potential future launch authorized generic bolstered strong supply position retain market leadership within ipe market rest world made progress regulatory market access commercial front well new partnership china second largest cardiovascular market globally amarins partner edding launched vascepa october high triglyceride indication additionally nmpa accepted regulatory filing cardiovascular risk reduction indication open potential future national reimbursement drug listing amarin also entered three new partnership across country focus rest world shift toward enabling partner obtain market access commercial uptake across key market finally research development medical team delivered important progress data publication medical education supporting brand globally build confidence science continue build momentum including additional data reduceit epa indeed seven abstract upcoming american college cardiology meeting april sharing coming week important operational progress supported financial position million cash debt aware due recent progress financial position announced plan share repurchase program million pleased share track complete necessary shareholder youk high court approval continue anticipate completing step second quarter share repurchase would commence shortly thereafter summary meaningful year operational momentum wellpositioned continue build would like hand call tom reilly review fourth quarter yearend financial performance tomtom reilly chief financial officer thank pat good morning everyone pleased report detail financial performance fourth quarter fourth quarter amarin reported total net revenue million including net product revenue million versus million third quarter million licensing royalty revenue yous product revenue million stable performance yous despite multiple competing generic market yous business continues provide profit supporting expansion europe revenue result include european product revenue million increase versus third quarter reflecting early revenue european market including spain united kingdom recognized million rest world revenue fourth quarter including product revenue million related commercial sale partner canada china middle east licensing royalty revenue million resulting primarily achievement edding cvrr milestone cost good sold fourth quarter million compared million excluding restructuring third quarter amarins overall gross margin net product revenue fourth quarter compared third quarter primarily due increase one supply sale partner edding moving operating expense operating expense million fourth quarter comprised million selling general administrative expense million research development expense second half amarin reported operating expense million represents million reduction operating expense versus first half track deliver previously announced million reduction operating expense july amarin reported net loss million fourth quarter basic diluted loss per share let turn effort result controlling cost effectively managing cash december amarin reported aggregate cash investment million importantly sixth consecutive quarter positive neutral cash flow generation amarin cash balance million higher compared december made progress controlling cost managing cash position cost reduction program renegotiating supply agreement continue focus cash preservation prudently invest right opportunity particularly europe based pricing reimbursement decision pending shareholder youk high court approval initiate shareholder repurchase program turn call back pat closing remark begin qa portion call patpatrick holt president chief executive officer thank tom financial overview result team focused operational momentum maximize shareholder value across three area business believe right plan focus operational momentum drive shareholder value strong future fundamental bestinclass science supporting vascepavazkepa large global opportunity impact cardiovascular patient team dedicated delivering result strong balance sheet finally thank colleague commitment dedication look forward driving shareholder value together mark let u begin qa portion callmark marmur vice president corporate communication thank pat announced last year enhance engagement company shareholder base facilitate connection investor amarin partnering say technology allow retail institutional shareholder submit upvote question selection answered amarin management today earnings call let u begin qa pat received number question company longterm strategy way plan maximize shareholder value would say investorspatrick holt president chief executive officer thanks question get question lot really important question believe best path forward u increase value put u best possible place future strategic option today focus current effort around operational momentum whether europe yous rest world shared earlier call really making progress three front provides u greater optimism optionality futuremark marmur vice president corporate communication great thanks pat second set question focus china asiapacific tell u progress commercial launch china status cardiovascular risk reduction regulatory filing china also broadly asiapacific share update effort partnerspatrick holt president chief executive officer know lot know know region pretty well let break part firstly china launch amarins partner edding really making important progress china remind everybody second largest cardiovascular market globally edding launched vascepa high triglyceride q give flavor edding sale force covering hospital includes around key opinion leader majority cardiologist three largest city beijing shanghai guangzhou summary launch progressing well structure agreement provides immediate profitability amarin let u move today also think future china reflect upon cardiovascular risk reduction indication nmpa accepted regulatory filing cardiovascular risk reduction open potential national reimbursement drug listing submission accepted clinical trial waiver meaning separate clinical trial required order reviewed approval team focused advancing submission together authority expect regulatory review process conclude asiapacific large region let touch area within region know last year entered partnership australia new zealand csl seqirus also asian market including south korea lotus pharmaceutical pleased share csl advancing pricing reimbursement process australia authority market partner lotus advancing regulatory discussion filing various authority across regionmark marmur vice president corporate communication great thanks pat information china asiapacific turning yous path toward growth market could potentially take market share product classespatrick holt president chief executive officer great question naturally yous revenue cash flow incredibly important business take step back think yous market stand today important remember ipe market yous highly genericized point focus continues maintain ipe market leadership result focused growing market really achieved highly atypical performance three year postloe end marketleading share able secure market leadership continue success exclusive contract led capability payer managed care medical area mentioned started strong position term exclusive contract remind everybody dynamic market watch closely continue ass optionality branded product beyond consider strategic alternative term taking share product class given generic dynamic view optimal strategymark marmur vice president corporate communication thank turning supply see demand increase europe rest world partner confident meet supply demandspatrick holt president chief executive officer important question strong relationship key supply partner last several year made really important progress renegotiating supply agreement ensure meet demand well reduce key supply commitment feel really confident meet supply demand moving forwardmark marmur vice president corporate communication one last question rd side say technology question amarin working advancing additional indication vascepavazkepapatrick holt president chief executive officer really pleased question came important question think core strength amarin term rd team ipe capability leadership team developed advanced molecule day one delivered reduceit data really global impact see today know team place continue look opportunity new indication update investor based potential future progress work take additional question would like thank shareholder submitted question via say technology platform committed continuing open transparent dialogue shareholder say technology platform one way trying increase engagement twoway dialogue look forward continuing hear answering question platform well opportunity moving forwardmark marmur vice president corporate communication thank update pat open qa additional question question answer operatorcertainly time conducting questionandanswer session operator instruction first question today roanna ruiz leerink partnersroanna ruiz leerink partner analyst hi good morning everyone could talk bit ongoing generic competition yous like trend seeing field expect term possible pressure vascepa net price next couple yearspatrick holt president chief executive officer hi roanna good morning thanks much question great hear know probably followed generic got regulatory approval generic also got price said know see term market dynamic market far remain fairly stable mentioned closed year started year strong position exclusive contract represents greater ipe volume end year start year know feeling really good position sure noted dynamic entrant market continue monitor closely would say far seen dynamic change seen historically obviously track closely know optionality short term well long term maximize economics u yousroanna ruiz leerink partner analyst yup make sense quick followup rest world noticed gaining traction could talk region expect might contribute momentum future growth revenue beyondpatrick holt president chief executive officer yeah great question mentioned really pleasing see progress think know signed new country take step back main revenue source china came board really coming canada part middle east north africa see certainly continued value coming existing partnership mentioned expect china progress opportunity think partnership start go signing regulatory process lotus market access reimbursement pricing csl seqirus australia new zealand starting see shift entering partnership really driving precommercial commercial output pleased progressing life cycle partnership alliance management would say see shift business toward revenue market access revenue generation internally mean beefing capability leadership support growthroanna ruiz leerink partner analyst got thankspatrick holt president chief executive officer know add really key part goal strategy rest world business provides immediate profitability usoperatoryour next question today jessica fye jp morganunknown speaker hi guy good morning nassan jessica fye question progress launching vascepa talk little bit know accelerate growth youk germany know come plan reenter market italy well thank youpatrick holt president chief executive officer thanks nassan great hear look europe obviously critical u key focus investment key focus whole organization move forward break think key launch market previously mentioned know youk quite individual market uptake youk typically slower making progress focused strategy key account signaled earlier believe estimate least patient therapy know building say moment launch last september expect spain faster uptake market proving true pleased progress uptake seeing spain spain national basis date see estimate around patient therapy important progress u know two key launch market u move reimbursement market know resubmit italy building previous strong scientific assessment expect italy pricing reimbursement conclude think germany next question know history germany topic taken step back redeveloping potential new strategy enter market working authority ass different way consider patient population relevant german german market working authority plan continue advance mentioned expect process conclude thanks much questionoperatoryour next question today louise chen cantor fitzgeraldunknown speaker hi team hi li louise thanks taking question first reiterated track deliver million annual saving think operating expense compared second quarter saved million third quarter million quarter expect similar number going forward gross margin dropped think going forward thank youtom reilly chief financial officer yeah great thanks tom thanks question audio gap related operating expense million track deliver expecting expectation expense mentioned reduced expense second half first half million cost basis approximately million per quarter expectation stay within range depending pricing reimbursement decision invest opportunity find way reduce cost overall expectation stay within million operating expense basis related question gross margin good question thanks picking seen versus q deterioration gross margin primarily due launch supply provided partner particular china china market moving forward providing product revenue point reduction margin impact quarter versus previous quarter know question expect margin moving forward think depends uptake china much product supply providing give update progress china marketunknown speaker thank muchoperatoryour next question paul choi goldman sachsunknown speaker hi everyone good morning khaleel calling paul thank much taking question guess question exclusive contract mentioned past renegotiated seen additional pushback generic enter market set threshold sort deterioration point company would pivot generic thank youpatrick holt president chief executive officer khaleel thanks much question look obviously track contract carefully see know would say annual basis renegotiate exclusive contract see annual impact pricing sort low doubledigit range typically something seeing consistently see necessarily significant change sort range see really pleasing know strong end year strong start year term landing negotiation netnet mean participating greater ipe market volume enabled u great managed care trade medical capability pull close market share retain market leadership second part question course track economics overall profitability incredibly closely specific scenario mind think attractive start become marginal plan place react based dynamic change change stand right focus extend branded life cycle long organization yous team perspective delivered highly atypical performance three year since loe provides incredibly important profit business particularly growth europe could happier term finish year start year well know highly dynamic monitor closelyunknown speaker got thank muchoperatorwe reached end questionandanswer session turn call patrick closing remarkspatrick holt president chief executive officer well thank attention thanks qa really appreciate interest look forward additional conversation important result coming day ahead thank time wish great day ahead thank youoperatoroperator signoff duration minutescall participantsmark marmur vice president corporate communicationspatrick holt president chief executive officertom reilly chief financial officerroanna ruiz leerink partner analystunknown speaker amrn analysis earnings call transcript article transcript conference call produced motley fool strive foolish best may error omission inaccuracy transcript article motley fool assume responsibility use content strongly encourage research including listening call reading company sec filing please see term condition additional detail including obligatory capitalized disclaimer liabilitythe motley fool position stock mentioned motley fool disclosure policy